Similar to the analyses of cDC1 and NK cell gene signatures, we observed a positive correlation with survival when we ranked melanoma, HNSC and TNBC patients according to expression of CCL5, XCL1, and XCL2 (Figures S7D and S7E). This evidence concerns the gene XCL1 and melanoma.